NEW YORK (GenomeWeb News) – Foundation Medicine said after the close of the market on Monday that it has extended and expanded an agreement with Novartis to provide molecular information and genomic profiling analysis in support of the drug manufacturer's clinical oncology programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.